BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22294370)

  • 1. Tachykinin receptor assays.
    Meini S; Maggi CA
    Curr Protoc Pharmacol; 2010 Mar; Chapter 4():Unit 4.10. PubMed ID: 22294370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
    Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
    Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin receptor subtypes characterized by biological assays.
    Regoli D; Nguyen QT; Jukic D
    Life Sci; 1994; 54(26):2035-47. PubMed ID: 8208061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
    Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors.
    Patacchini R; Astolfi M; Brown MC; Maggi CA
    Neuropeptides; 1991 Oct; 20(2):109-14. PubMed ID: 1665895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization with a selective agonist discriminates between multiple tachykinin receptors.
    Laufer R; Gilon C; Chorev M; Selinger Z
    J Pharmacol Exp Ther; 1988 May; 245(2):639-43. PubMed ID: 2835478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists.
    Dion S; D'Orléans-Juste P; Drapeau G; Rhaleb NE; Rouissi N; Tousignant C; Regoli D
    Life Sci; 1987 Nov; 41(20):2269-78. PubMed ID: 2824947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
    Maggi CA; Patacchini R; Feng DM; Folkers K
    Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
    Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
    Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
    Ellis JL; Undem BJ; Kays JS; Ghanekar SV; Barthlow HG; Buckner CK
    J Pharmacol Exp Ther; 1993 Oct; 267(1):95-101. PubMed ID: 8229792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pinacidil suppression on 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro.
    Yuan YM; Xu DY; Hu GY
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):31-5. PubMed ID: 10375754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro opioid receptor assays.
    Taylor DA
    Curr Protoc Pharmacol; 2011 Dec; Chapter 4():Unit 4.8.1-34. PubMed ID: 22147348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
    Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
    Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraethylammonium and 4-aminopyridine enhancement of 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro.
    Yuan YM; Yang HH; Hu GY
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):451-5. PubMed ID: 10375808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractile responses induced by physalaemin, an analogue of substance P, in the rat esophagus.
    Shiina T; Shima T; Hirayama H; Kuramoto H; Takewaki T; Shimizu Y
    Eur J Pharmacol; 2010 Feb; 628(1-3):202-6. PubMed ID: 19958761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological profiles of a novel tachykinin NK-2 receptor antagonist, TAC-363].
    Higashide Y; Yatabe Y; Arai Y; Nakajima Y; Shibata M; Yamaura T
    Yakugaku Zasshi; 1996 Nov; 116(11):884-91. PubMed ID: 8981832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.
    Nguyen-Le XK; Nguyen QT; Gobeil F; Pheng LH; Emonds-Alt X; Brelière JC; Regoli D
    Pharmacology; 1996 May; 52(5):283-91. PubMed ID: 8807672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.